Información de la publicación

Portal del Investigador > en > Publications > publication-detail

Development and validation of a predictive model for early treatment response in first-episode psychosis using clinical and genetic data

Other conference communications or articles related to authors from the University of Cantabria

A generalisable normative deep learning approach for the discrimination of psychiatric disorders based on neuroanatomy - Conference object
Biomarkers as proxies for cognitive reserve: the role of high density lipoprotein cholesterol in first episode of psychosis - Conference object
Antipsychotic treatment effectiveness in first episode of psychosis-3 open-label randomized clinical trial comparing aripiprazole vs risperidone: analyses of adverse effects after 1-year follow-up - Conference object
Antipsychotic treatment effectiveness in first episode of psychosis-3 open-label randomized clinical trial comparing aripiprazole and risperidone for first-episode psychosis: a long-term effectiveness analysis - Article
A generalizable normative deep learning approach for the discrimination of psychiatric disorders based on neuroanatomy - Conference object
Exploring the cognitive effects of benzodiazepine utilization in a spanish partial hospitalization unit - Conference object
Unveiling persistent negative symptoms in first-episode-psychosis: exploring sociodemographic and diagnostic profiles - Conference object
Gender differences in mental health and hospital emergency department use before suicide in northern Spain: a retrospective study - Conference object
GRIN2B: SNPs and haplotypes association with treatment resistant depression severity and treatment-response to intranasal esketamine - Conference object
The slowing puzzle: cytokine clues to processing and psychomotor speed deficits in first-episode of schizophrenia - Conference object
Can esketamine save lives? Real-world effectiveness on suicide risk in treatment-resistant depression - Conference object
Mantaining clinical improvement with intranasal esketamine in treatment resistant depression - Conference object
Real world multicenter evidence on intranasal esketamine in treatment-resistant depression: from remission to recovery - Conference object

Congress: ECNP Congress (38º: 2025: Amsterdam)

Publisher: Elsevier B.V.

Year of publication: 2026

No. of pages: 1

Publication type: Conference object

DOI: 10.1016/j.nsa.2025.106847

ISSN: 2772-4085

Publication Url: https://www.sciencedirect.com/science/article/pii/S2772408525014395?via%3Dihub

Read publication

Authorship

JULIÀ MELIS, L.

VICTOR ORTIZ GARCIA DE LA FOZ

SEGURA, À. G.

ALEMANY NAVARRO, M.

CARRASCO, J. L.

CUESTA ZORITA, M. J.

SPUCH, C.

GONZÁLEZ PINTO, A.

IBÁÑEZ, Á.

USALL, J.

ROMERO LÓPEZ ALBERCA, C.

CATALÁN, A.

MANÉ, A.

AMORETTI, S.

CRESPO FACORRO, B.

JAVIER VAZQUEZ BOURGON

MAS, S.

Download reference

Bib Ris

Back

Researchers portal

Portal del personal investigador

Development and validation of a predictive model for early treatment response in first-episode psychosis using clinical and genetic data

Authorship

Download reference